Researchers have been excited about the medication , a novel dual compound showing significant results in early trials for size loss . It acts by targeting both hormones : GLP-1 and GIP, which , when https://nanniejczn785872.blogsuperapp.com/41308277/a-new-possibility-for-size-loss